Andreas I. Papadakis

1.3k total citations
32 papers, 734 citations indexed

About

Andreas I. Papadakis is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Andreas I. Papadakis has authored 32 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Cell Biology and 7 papers in Epidemiology. Recurrent topics in Andreas I. Papadakis's work include RNA regulation and disease (8 papers), Cancer Genomics and Diagnostics (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Andreas I. Papadakis is often cited by papers focused on RNA regulation and disease (8 papers), Cancer Genomics and Diagnostics (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Andreas I. Papadakis collaborates with scholars based in Canada, Greece and United Kingdom. Andreas I. Papadakis's co-authors include Antonis E. Koromilas, Philippos Peidis, Dionissios Baltzis, Hala Muaddi, Sidong Huang, Urszula Kazimierczak, Shirin Kazemi, Olivier Pluquet, Like Qu and Randal J. Kaufman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Andreas I. Papadakis

30 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas I. Papadakis Canada 14 515 288 159 107 84 32 734
Carolyn Kemp United States 9 381 0.7× 186 0.6× 256 1.6× 112 1.0× 123 1.5× 11 747
Zineb Mounir Canada 10 380 0.7× 212 0.7× 122 0.8× 59 0.6× 87 1.0× 22 582
Donghong Ju United States 16 679 1.3× 276 1.0× 175 1.1× 112 1.0× 116 1.4× 41 846
Nancy L. Maas United States 9 873 1.7× 220 0.8× 148 0.9× 182 1.7× 119 1.4× 10 1.1k
Laura Rodríguez de la Ballina Norway 12 455 0.9× 149 0.5× 235 1.5× 143 1.3× 134 1.6× 18 848
Daria Sicari Italy 12 277 0.5× 193 0.7× 94 0.6× 122 1.1× 66 0.8× 14 475
Wen‐An Wang Canada 11 350 0.7× 208 0.7× 121 0.8× 70 0.7× 32 0.4× 21 610
Michael Ewing United States 9 253 0.5× 241 0.8× 309 1.9× 128 1.2× 100 1.2× 13 664
Qin Yu United States 13 393 0.8× 130 0.5× 138 0.9× 145 1.4× 145 1.7× 21 665

Countries citing papers authored by Andreas I. Papadakis

Since Specialization
Citations

This map shows the geographic impact of Andreas I. Papadakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas I. Papadakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas I. Papadakis more than expected).

Fields of papers citing papers by Andreas I. Papadakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas I. Papadakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas I. Papadakis. The network helps show where Andreas I. Papadakis may publish in the future.

Co-authorship network of co-authors of Andreas I. Papadakis

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas I. Papadakis. A scholar is included among the top collaborators of Andreas I. Papadakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas I. Papadakis. Andreas I. Papadakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perlman, Kelly, Volodymyr Yerko, Andreas I. Papadakis, et al.. (2025). Characterizing oligodendrocyte-lineage cells and myelination in the basolateral amygdala: Insights from a novel methodology in postmortem human brain. Psychiatry Research. 351. 116653–116653.
2.
Papadakis, Andreas I., et al.. (2023). Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer. Lung Cancer. 181. 107247–107247. 1 indexed citations
3.
Steinberg, Christian, Nathalie Gaudreault, Andreas I. Papadakis, et al.. (2023). Leucocyte-derived micro-RNAs as candidate biomarkers in Brugada syndrome. EP Europace. 25(6). 5 indexed citations
4.
Stockley, Tracy, Bernard Lo, John F. DeCoteau, et al.. (2023). Consensus Recommendations to Optimize the Detection and Reporting of NTRK Gene Fusions by RNA-Based Next-Generation Sequencing. Current Oncology. 30(4). 3989–3997. 3 indexed citations
5.
Janssen, Sanne, et al.. (2023). BORIS / CTCFL ‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells. Pigment Cell & Melanoma Research. 36(3-4). 299–313. 3 indexed citations
6.
Agulnik, Jason, Andreas I. Papadakis, Carmela Pepe, et al.. (2022). Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC). Current Oncology. 29(2). 1107–1116. 6 indexed citations
7.
Brukner, Ivan, Shaun Eintracht, Andreas I. Papadakis, et al.. (2020). Maximizing confidence in a negative result: Quantitative sample adequacy control. Journal of Infection and Public Health. 13(7). 991–993. 14 indexed citations
8.
Xue, Yibo, Xianbing Zhu, Brian Meehan, et al.. (2020). SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors. The Journal of Pathology. 252(1). 77–87. 13 indexed citations
9.
Santiago, Raoul, Nathalie A. Johnson, Andreas I. Papadakis, et al.. (2019). Changes in Tumor Immune Micro-Environment in Diffuse Large B-Cell Lymphoma (DLBCL): A Comparative Study of Relapsed Versus Diagnostic DLBCL. Blood. 134(Supplement_1). 3968–3968. 1 indexed citations
10.
Karimzadeh, Mehran, Pouria Jandaghi, Andreas I. Papadakis, et al.. (2018). Aberration hubs in protein interaction networks highlight actionable targets in cancer. Oncotarget. 9(38). 25166–25180. 2 indexed citations
11.
Zagoriti, Zoi, George Lagoumintzis, George Papathanasiou, et al.. (2018). Evidence for association of STAT4 and IL12RB2 variants with Myasthenia gravis susceptibility: What is the effect on gene expression in thymus?. Journal of Neuroimmunology. 319. 93–99. 4 indexed citations
12.
Perron, Gabrielle, Pouria Jandaghi, Mehran Karimzadeh, et al.. (2018). A General Framework for Interrogation of mRNA Stability Programs Identifies RNA-Binding Proteins that Govern Cancer Transcriptomes. Cell Reports. 23(6). 1639–1650. 50 indexed citations
13.
Khanna, Rajesh, et al.. (2015). Phosphorylation of the translation initiation factor eIF2α at serine 51 determines the cell fate decisions of Akt in response to oxidative stress. Cell Death and Disease. 6(1). e1591–e1591. 87 indexed citations
14.
Papadakis, Andreas I., Chong Sun, Theo Knijnenburg, et al.. (2015). SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer. Cell Research. 25(4). 445–458. 29 indexed citations
15.
Zhou, Yiwang, Paola Blanchette, Naila Chughtai, et al.. (2015). The Human Adenovirus Type 5 E4orf4 Protein Targets Two Phosphatase Regulators of the Hippo Signaling Pathway. Journal of Virology. 89(17). 8855–8870. 11 indexed citations
16.
Papadakis, Andreas I., et al.. (2011). Development of transgenic mice expressing a conditionally active form of the eIF2α kinase PKR. genesis. 49(9). 743–749. 2 indexed citations
17.
Papadakis, Andreas I., Efrosyni Paraskeva, Philippos Peidis, et al.. (2010). eIF2α Kinase PKR Modulates the Hypoxic Response by Stat3-Dependent Transcriptional Suppression of HIF-1α. Cancer Research. 70(20). 7820–7829. 43 indexed citations
18.
Peidis, Philippos, Andreas I. Papadakis, Hala Muaddi, Stéphane Richard, & Antonis E. Koromilas. (2010). Doxorubicin bypasses the cytoprotective effects of eIF2α phosphorylation and promotes PKR-mediated cell death. Cell Death and Differentiation. 18(1). 145–154. 46 indexed citations
19.
Peidis, Philippos, et al.. (2010). HDAC pharmacological inhibition promotes cell death through the eIF2α kinases PKR and GCN2. Aging. 2(10). 669–677. 12 indexed citations
20.
Baltzis, Dionissios, Olivier Pluquet, Andreas I. Papadakis, et al.. (2007). The eIF2α Kinases PERK and PKR Activate Glycogen Synthase Kinase 3 to Promote the Proteasomal Degradation of p53. Journal of Biological Chemistry. 282(43). 31675–31687. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolyn Kemp Breakdown of academic impact, for papers by Zineb Mounir Breakdown of academic impact, for papers by Donghong Ju Breakdown of academic impact, for papers by Nancy L. Maas Breakdown of academic impact, for papers by Laura Rodríguez de la Ballina Breakdown of academic impact, for papers by Daria Sicari Breakdown of academic impact, for papers by Wen‐An Wang Breakdown of academic impact, for papers by Michael Ewing Breakdown of academic impact, for papers by Qin Yu
Rankless by CCL
2026